Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/26 19:03 | 6/30/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Fitzgerald Meghan | D | 1 | S.d | -349 | 34.90 | 0 | -10 | 43 | D | |||||||||||||||||
7/1/26 18:34 | 6/29/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Epperly Melissa B, | D | 1 | S.d | -610 | 34.38 | 0 | -18 | 16 | D | |||||||||||||||||
6/30/26 20:38 | 6/26/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | D | 1 | S.m | -56,444 | 34.46 | 0 | -1,638 | 15,438 | M | |||||||||||||||||
6/30/26 20:30 | 6/26/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Gold Daniel Allen | D | 1 | S.m | -49,354 | 34.32 | 0 | -1,438 | 13,689 | I | |||||||||||||||||
6/30/26 19:59 | 6/26/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Qvt Financial LP | NY | H | Director | 1 | S.m | -49,354 | 34.32 | 0 | -1,438 | 13,689 | I | |||||||||||||||
6/29/26 18:23 | 6/25/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | DO | P,CIO | 1 | S.dm | -34,105 | 34.11 | 0 | -1,000 | 18,678 | D | ||||||||||||||||
6/26/26 18:13 | 6/24/26 | ROIV | Health | Drug | Pharmaceutical Preparations | Venker Eric | O | P,Immuno | 3 | S.d | -18,603 | 31.01 | 0 | -600 | 1,648 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |